These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2305682)

  • 1. Medical costs of coronary artery disease in the United States.
    Wittels EH; Hay JW; Gotto AM
    Am J Cardiol; 1990 Feb; 65(7):432-40. PubMed ID: 2305682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical costs of coronary artery disease in the United States.
    Russell MW; Huse DM; Drowns S; Hamel EC; Hartz SC
    Am J Cardiol; 1998 May; 81(9):1110-5. PubMed ID: 9605051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis.
    Kim C; Kwok YS; Saha S; Redberg RF
    Am Heart J; 1999 Jun; 137(6):1019-27. PubMed ID: 10347326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
    Henderson RA; Pocock SJ; Sharp SJ; Nanchahal K; Sculpher MJ; Buxton MJ; Hampton JR
    Lancet; 1998 Oct; 352(9138):1419-25. PubMed ID: 9807988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions.
    Fearon WF; Yeung AC; Lee DP; Yock PG; Heidenreich PA
    Am Heart J; 2003 May; 145(5):882-7. PubMed ID: 12766748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of costs of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft surgery (CABG) for patients with angina pectoris.
    Cheng TO
    Eur Heart J; 1991 Feb; 12(2):288. PubMed ID: 1904352
    [No Abstract]   [Full Text] [Related]  

  • 7. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris.
    van den Brand M; van Halem C; van den Brink F; de Feyter P; Serruys P; Suryapranata H; Meeter K; Bos E; van Dalen FJ
    Eur Heart J; 1990 Aug; 11(8):765-71. PubMed ID: 2118854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of cost in treatment selection for patients with coronary heart disease.
    Mark DB
    Ann Thorac Surg; 1996 Feb; 61(2 Suppl):S12-5; discussion S33-4. PubMed ID: 8572825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is medical treatment for angina the most cost-effective option?
    Cleland JG; Walker A
    Eur Heart J; 1997 May; 18 Suppl B():B35-42. PubMed ID: 9152668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
    Chino M; Sasaki T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():632-7. PubMed ID: 12735043
    [No Abstract]   [Full Text] [Related]  

  • 12. Can improved quality of care reduce the costs of managing angina pectoris?
    Cleland JG
    Eur Heart J; 1996 Mar; 17 Suppl A():29-40. PubMed ID: 8737199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.
    Farzaneh-Far A; Borges-Neto S
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):746-53. PubMed ID: 22086945
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Brown RE; Henderson RA; Koster D; Hutton J; Simoons ML
    Eur Heart J; 2002 Jan; 23(1):50-8. PubMed ID: 11741362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial.
    Sculpher MJ; Seed P; Henderson RA; Buxton MJ; Pocock SJ; Parker J; Joy MD; Sowton E; Hampton JR
    Lancet; 1994 Oct; 344(8927):927-30. PubMed ID: 7934351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome.
    Brosa M; Rubio-Terrés C; Farr I; Nadipelli V; Froufe J
    Pharmacoeconomics; 2002; 20(14):979-87. PubMed ID: 12403638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI).
    Yock CA; Boothroyd DB; Owens DK; Winston C; Hlatky MA
    Am Heart J; 2000 Oct; 140(4):556-64. PubMed ID: 11011328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness analysis of an invasive therapeutic approach to coronary disease].
    Urban P
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1661-4. PubMed ID: 8927970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris.
    Stammen F; De Scheerder I; Glazier JJ; Van Lierde J; Vrolix M; Willems JL; De Geest H; Piessens J
    Am J Cardiol; 1992 Jun; 69(19):1533-7. PubMed ID: 1598865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.